Clinical trials recruiting in Jordan, Hong Kong
3
Recruiting trials
7
Conditions
Phase breakdown
Phase 1 1Phase 2 1Phase 3 2
Conditions recruiting in Jordan, Hong Kong
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Breast Neoplasms | 1 |
| Breast cancer | 1 |
| HR Low-Positive/HER2-Negative Breast Neoplasms | 1 |
| Lung Neoplasm Malignant | 1 |
| Non-small Cell Lung Cancer | 1 |
| Triple Negative Breast Neoplasms | 1 |
Recruiting trials in Jordan, Hong Kong
- A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Common questions
How many clinical trials are recruiting in Jordan, Hong Kong?
3 recruiting trials have at least one study site in Jordan, Hong Kong.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.